Earlier this year we published our approach using a catalytic antibody to not only sequester carfentanil, but inactivate it. Ming will be presenting this paper along with other great work he has done at his defense in September! https://t.co/dq4LZwDdaL
NEW #ASAP Therapeutic monoclonal antibody for heroin abuse/overdose by @LabJanda shows vaccines have been mistargeting heroin’s metabolites for decades and should refocus efforts on heroin itself.
Read here: https://t.co/ol45jahiD6
Collaboration with Prof. Andrianov at the University of Maryland showed PCEP to be a promising adjuvant for anti-drug vaccines. When hapten design is already optimized, finding new adjuvants for intranasal immunization is the way to go. Check it out here: https://t.co/lX5lzfYjlU
Our most recent publication in JMC: A Vaccine against Benzimidazole-Derived New Psychoactive Substances That Are More Potent Than Fentanyl https://t.co/zDpAMe7j0J
Congrats Jinny and Hyeri!
During National Immunization Awareness Month (August 2021), we congratulate Dr. Kim D Janda of Scripps Clinic and Research Institute -- Recognized as an Expertscape Expert in Synthetic Vaccines.
https://t.co/0fnQg6q7vY
Check out a synthetic fluorescent MYC probe we found and how we developed a high-throughput screening assay that found a promising lead compound. https://t.co/nVa3FDxw0u
A new paper from our lab is out on Chemrxiv that used structure-based drug design as a way to develop inhibitors of botulinum neurotoxin A protease. Congrats @LewisTu52514415 and @alexanderln91! https://t.co/QZiFfppYIQ
Our recent publication on irreversible bifunctional inhibitors of botulinum neurotoxin A is out in RSC Med Chem, check it out! Congrats @LewisTu52514415 and @alexanderln91 🥳 https://t.co/O0MWszFtlX
Congrats to Lisa on the paper published today on two synthetic opioid vaccines! It not only elicits high-affinity antibodies against carfentanil and fentanyl, but also offers protection against opioid-induced respiratory depression. https://t.co/25ga1oCiHE
"The complexity of brain chemistry involved is extremely difficult to target with a drug. But if you have a good enough #antibody, it acts like a vacuum cleaner to suck the drug out of the brain." Prof. Kim Janda's immunopharmacotherapy for #addiction https://t.co/hZjTcQZQvU
"The complexity of brain chemistry involved is extremely difficult to target with a drug. But if you have a good enough #antibody, it acts like a vacuum cleaner to suck the drug out of the brain." Prof. Kim Janda's immunopharmacotherapy for #addiction https://t.co/hZjTcQZQvU